Sepsis is a common condition managed in the emergency department. Current diagnosis relies on physiologic criteria and suspicion of a source of infection using history, physical examination, laboratory studies, and imaging studies. The infection triggers a host response with the aim to destroy the pathogen, and this response can be measured. A reliable biomarker for sepsis should assist with earlier diagnosis, improve risk stratification, or improve clinical decision making. Current biomarkers for sepsis include lactate, troponin, and procalcitonin. This article discusses the use of lactate, procalcitonin, troponin, and novel biomarkers for use in sepsis.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2gQqN2T
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Neonatal-Onset Multisystem Inflammatory Disease (NOMID) or Chronic Infantile Neurologic Cutaneous Articular (CINCA) syndrome is a...
-
Academic Emergency Medicine, Volume 0, Issue ja , -Not available-. from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2M...
-
Jupiter, FL (November, 2016) – Responder Ventures, LLC announces the formal launch of its industry-leading venture capital firm dedicated to...
-
Abstract Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are common in women of childbearing age and are often treated with terato...
-
from EMS via xlomafota13 on Inoreader http://ift.tt/1VEcmwT
-
Resuscitation from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/1N8kkFN
-
BY EMS1 Staff AUSTIN, Texas — A paramedic and podcast host’s movement to support the partner of fallen FDNY EMT Yadira Arroyo has gone globa...
-
Abstract Purpose To evaluate the frequency, characteristics, and clinical significance of transient hyperintensity foci on T1-weighted i...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου